Cargando…

Regulation of Αlpha-Synuclein Gene (SNCA) by Epigenetic Modifier TET1 in Parkinson Disease

PURPOSE: Deregulation of SNCA encoding α-synuclein (α-SYN) has been associated with both the familial and sporadic forms of Parkinson disease (PD). Epigenetic regulation plays a crucial role in PD. The intron1 of SNCA harbors a large unmethylated CpG island. Ten-eleven translocation methylcytosine d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guhathakurta, Subhrangshu, Song, Min Kyung, Basu, Sambuddha, Je, Goun, Cristovao, Ana Clara, Kim, Yoon-Seong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Continence Society 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767688/ https://www.ncbi.nlm.nih.gov/pubmed/36503211 http://dx.doi.org/10.5213/inj.2222206.103

Ejemplares similares

Targeted attenuation of elevated histone marks at SNCA alleviates α‐synuclein in Parkinson's disease
por: Guhathakurta, Subhrangshu, et al.
Publicado: (2021)

Hypomethylation of intron1 of α-synuclein gene does not correlate with Parkinson’s disease
por: Guhathakurta, Subhrangshu, et al.
Publicado: (2017)

Transcriptional mutagenesis by 8-oxodG in α-synuclein aggregation and the pathogenesis of Parkinson's disease
por: Basu, Sambuddha, et al.
Publicado: (2015)

A novel tool for monitoring endogenous alpha-synuclein transcription by NanoLuciferase tag insertion at the 3′end using CRISPR-Cas9 genome editing technique
por: Basu, Sambuddha, et al.
Publicado: (2017)

A novel extended form of alpha-synuclein 3′UTR in the human brain
por: Je, Goun, et al.
Publicado: (2018)

Transcriptional mutagenesis of α-synuclein caused by DNA oxidation in Parkinson’s disease pathogenesis
por: Basu, Sambuddha, et al.
Publicado: (2023)

Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson’s Disease
por: Bobela, Wojciech, et al.
Publicado: (2015)

Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson’s disease patients
por: Kang, Wenyan, et al.
Publicado: (2016)

The Impact of SNCA Variations and Its Product Alpha-Synuclein on Non-Motor Features of Parkinson’s Disease
por: Magistrelli, Luca, et al.
Publicado: (2021)

SNCA-AS1 in aging and Parkinson’s disease
por: Carelli, Stephana, et al.
Publicado: (2022)

The SNCA-Rep1 Polymorphic Locus: Association with the Risk of Parkinson’s Disease and SNCA Gene Methylation
por: Iakovenko, E. V., et al.
Publicado: (2020)

Precise epigenomic editing with a SunTag-based modular epigenetic toolkit
por: Guhathakurta, Subhrangshu, et al.
Publicado: (2022)

Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human α-synuclein in transgenic mouse brain
por: Cronin, Kenneth D., et al.
Publicado: (2009)

SNCA Triplication Parkinson's Patient's iPSC-derived DA Neurons Accumulate α-Synuclein and Are Susceptible to Oxidative Stress
por: Byers, Blake, et al.
Publicado: (2011)

Genetic Variants of the α-Synuclein Gene SNCA Are Associated with Multiple System Atrophy
por: Al-Chalabi, Ammar, et al.
Publicado: (2009)

Snca-GFP Knock-In Mice Allows Tracking the Endogenous α-Synuclein in Action
por: Er, Safak
Publicado: (2021)

Piperine promotes autophagy flux by P2RX4 activation in SNCA/α-synuclein-induced Parkinson disease model
por: Li, Ruolin, et al.
Publicado: (2021)

α‐Synuclein antisense transcript SNCA‐AS1 regulates synapses‐ and aging‐related genes suggesting its implication in Parkinson's disease
por: Rey, Federica, et al.
Publicado: (2021)

The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson’s disease
por: Lau, Heather H. C., et al.
Publicado: (2023)

Variants in the SNCA Locus Are Associated With the Progression of Parkinson's Disease
por: Luo, Ningdi, et al.
Publicado: (2019)

A novel autophagy modulator 6-Bio ameliorates SNCA/α-synuclein toxicity
por: Suresh, S. N., et al.
Publicado: (2017)

Network Analysis Implicates Alpha-Synuclein (Snca) in the Regulation of Ovariectomy-Induced Bone Loss
por: Calabrese, Gina, et al.
Publicado: (2016)

SNCA genetic lowering reveals differential cognitive function of alpha-synuclein dependent on sex
por: Brown, Jennifer L., et al.
Publicado: (2022)

New SNCA mutation and structures of α-synuclein filaments from juvenile-onset synucleinopathy
por: Yang, Yang, et al.
Publicado: (2023)

Metal Exposure and SNCA rs356219 Polymorphism Associated With Parkinson Disease and Parkinsonism
por: Lucchini, Roberto G., et al.
Publicado: (2020)

Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease
por: Oczkowska, Anna, et al.
Publicado: (2013)

Festination Correlates with SNCA Polymorphism in Chinese Patients with Parkinson's Disease
por: Zheng, Jinhua, et al.
Publicado: (2017)

Genetic Analysis and Literature Review of SNCA Variants in Parkinson's Disease
por: Guo, Yi, et al.
Publicado: (2021)

SNCA 3′ UTR Genetic Variants in Patients with Parkinson’s Disease
por: Blažeković, Antonela, et al.
Publicado: (2021)

SNCA Gene Methylation in Parkinson’s Disease and Multiple System Atrophy
por: Fedotova, Ekaterina Yu., et al.
Publicado: (2023)

Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seeding
por: Wurster, Isabel, et al.
Publicado: (2022)

Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells
por: Oliveira, L M A, et al.
Publicado: (2015)

Rodent models of Parkinson's disease: beyond the motor symptomatology
por: Campos, Filipa L., et al.
Publicado: (2013)

Generation of two human induced pluripotent stem cell lines (iPSCs) with mutations of the α-synuclein (SNCA) gene associated with Parkinson’s disease; the A53T mutation (LCSBi003) and a triplication of the SNCA gene (LCSBi007)
por: Novak, Gabriela, et al.
Publicado: (2021)

S157: NILOTINIB VS. NILOTINIB + PEG-INTERFERON ΑLPHA INDUCTION AND NILOTINIB OR PEG-INTERFERON ΑLPHA MAINTENANCE THERAPY FOR NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS. THE TIGER TRIAL.
por: Hochhaus, Andreas, et al.
Publicado: (2023)

Alpha‐synuclein dynamics in induced pluripotent stem cell‐derived dopaminergic neurons from a Parkinson’s disease patient (PARK4) with SNCA triplication
por: Fukusumi, Hayato, et al.
Publicado: (2021)

Alpha‐synuclein mRNA isoform formation and translation affected by polymorphism in the human SNCA 3ʹUTR
por: Barrie, Elizabeth S., et al.
Publicado: (2018)

Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models
por: Prieto Huarcaya, Susy, et al.
Publicado: (2022)

The Parkinson Disease gene SNCA: Evolutionary and structural insights with pathological implication
por: Siddiqui, Irum Javaid, et al.
Publicado: (2016)

SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population
por: Trotta, Luca, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_d80d97dkt458bm9137s669fnu3